Building Trust in Healthcare: The Medical Affairs Perspective

Reflections after presenting at Google for Startups

Fresh off the stage from my recent presentation at Google for Startups, I’ve been reflecting deeply on the core component of success in our industry. Whether you are in MedTech or Pharma, the foundation of every interaction is not the product, the device, or the drug. It is Trust.

For Medical Affairs teams, trust isn’t a “nice-to-have”; it is the essential currency that allows us to operate. However, trust is fragile—it takes years to build and seconds to destroy.

Drawing on my experience, I want to explore how Medical Affairs can cultivate this trust through three core pillars: Scientific Exchange, Medical Education, and Data Generation.

Scientific Exchange: Earning Your Seat at the Table

Having a PhD, PharmD, or MD gets you in the door. But staying in the room? That requires proving you’re a true peer.

When a Medical Science Liaison (MSL) meets with a renowned professor, that professor isn’t looking for a sales pitch or basic education. They’re seeking intellectual partnership. They want someone who:

• Knows the product inside-out (better than they do)
• Understands the field (as well as they do)
• Brings external insights (that they don’t have access to)

This is where the real value exchange happens. MSLs aggregate insights across institutions, bridging silos that academic circles can’t easily cross. They share what they’ve learned from other scientific leaders, creating a knowledge network that benefits everyone.

Here are some practical tips:

• Treat discussions as peer-to-peer science, not as a one-sided sales pitch. Your credibility starts with the audience recognizing you as a knowledgeable peer, often evidenced by advanced training (PhD, PharmD, MD) and current engagement with the field.
• Demonstrate current, signal-to-noise literacy. Be the MSL who tracks the latest papers, conference chatter, and evolving debates. Share insights that are genuinely informational, not only product-centered.
• Build your “scientific currency” by curating up-to-date knowledge. Use a structured approach to reading and synthesis: identify the key questions, surface competing hypotheses, and suggest balanced interpretations.
• Practical tip: aim to bring fresh perspectives from a broad network of scientific leaders while clearly attributing sources. Avoid over-reliance on internal data; acknowledge external voices and ongoing debates.

But maintaining this level of expertise requires constant learning. The science doesn’t stand still. This is precisely why we built Briefio—to help busy professionals convert dense scientific papers into digestible summaries they can absorb anywhere, anytime. Because when an MSL demonstrates they’ve read the latest papers and understand the current debates, they earn trust. In return, they gain priceless strategic insights for their company.

Trust earned: Intellectual credibility

Medical Education: Creating Value Beyond the Product

Non-promotional medical education events are trust-building engines—when done right.

The key word is non-promotional. This means:

• The content is broader than your product
• The topics are scientifically or clinically relevant first, strategically aligned second
• Scientific leaders often co-develop or present the content

Think about what this creates: A platform where respected voices can advocate for issues they care about. The company amplifies their voice, helps them raise awareness about important problems, and connects them with peers for best-practice exchange.

For attending physicians, the value proposition is clear: high-quality scientific education, networking opportunities, and practical insights they can apply. If the content is so valuable that doctors would pay to attend even without company sponsorship, you’ve achieved something remarkable.

The separation from sales is critical. Mix in promotional content, and trust evaporates. Keep it scientifically excellent and neutral, and trust compounds over time.

Here are some practical tips:

• Non-promotional focus is essential. Educational activities should not feel like a sales event. They should explore scientifically relevant topics with integrity and neutrality.
• Co-create with scientific leaders. Involve researchers early to identify topics that matter to the field, not only those aligned with a product. This builds credibility and broadens the dialogue beyond a single company.
• Ensure quality and relevance. Choose topics that address real clinical gaps, methodological challenges, or emerging areas of patient care. Provide opportunities for attendees to network, exchange best practices, and share real-world experiences.
• Measure impact and trust, not just attendance. Evaluate whether the content informed practice, sparked new collaborations, or led to practice improvement. Consider attendee feedback, knowledge gain, and downstream scholarly activity (e.g., publications, presentations, new guidelines discussions).
• Be transparent about funding and non-promotional aims. If an event is funded, clarify the scope and guard against any impression of promotional influence.

Trust earned: Educational partnership and platform amplification

Data Generation: Co-Creating Scientific Knowledge

Data generation comes in two flavors, each building trust differently:

Company-Driven Local Data Generation

This is where true scientific partnerships can flourish. The process:

1. Identify gaps together through scientific exchange and advisory boards
2. Co-design studies with scientific leaders as partners, not just consultants
3. Collaborate on protocols, often with support from medical writing companies or CROs
4. Share authorship and presentations

When companies operate at the highest scientific level throughout this process, scientific leaders see them as genuine peers. The partnership becomes real—a think-tank rather than a transaction. The scientific leader gains publications and partnerships; the company gains data and credibility.

Here are some practical tips:

• Design with independence and scientific rigor. For local datageneration, collaborate early with scientific leaders to identify gaps, define endpoints, and draft protocols. Ensure non-biased design, appropriate statistical plans, and clinically meaningful questions.
• Shared authorship and ongoing engagement build trust. Co-authorship with scientific leaders, transparent presentation and discussion of results, and public dissemination of findings reinforce credibility and demonstrate true partnership.

Trust earned: Scientific partnership and co-creation

Investigator-Initiated Studies (IIS)

IIS programs are trust-building exercises in restraint and transparency.

The company provides financial support but nothing else. The investigator chooses the topic, designs the protocol, analyzes data, and writes independently. Medical Affairs can introduce scientists to Areas of Interest (AOIs) and help navigate the application process, but must never suggest specific topics or influence outcomes.

This firewall is essential. There can be zero perception that financial support is tied to prescribing behavior. The cleaner this separation, the stronger the trust from the medical community.

The challenge? Managing expectations when projects get rejected or funding is limited. This requires exceptional transparency and communication—it’s one of the most difficult aspects of an MSL’s job. Done well, it builds tremendous trust. Done poorly, it destroys relationships.

When IIS programs generate meaningful studies that close true medical gaps with scientific excellence, trust multiplies across the entire medical community.

Here are some pracitcal tips:

• Use the Areas of Interests and communicate those with the Scientific Leaders, explain the independent part carefully and transparent.
• Support the process, but stay away from influencing the scientific narrative.
• Governance, transparency, and expectations management are non-negotiable. In IIS, maintain clear separation between scientific leadership and company influence.
• For IIS, implement a rigorous budget application process and ensure there is no direct or implied link between outcomes and prescribing behavior.
• Manage expectations openly—investigators may have high hopes, and clear communication is essential to maintain trust.

Trust earned: Independence and scientific integrity

The Fragility of Trust

All three pillars share a common truth: trust takes years to build and seconds to destroy.

This is why Medical Affairs teams obsess over ethics, transparency, and scientific excellence. It’s why they maintain strict separation from commercial teams. It’s why they reject shortcuts that might deliver quick wins but erode credibility.

As someone building in the healthcare space with Briefio, I’m constantly reminded that our users—scientists, doctors, and lifelong learners—need to trust that the summaries we provide are accurate, the audio conversions faithful, and the platform secure. We’re part of their scientific workflow, and that’s a responsibility we take seriously.

For Medical Affairs professionals reading this: the work you do building trust is foundational. It’s what makes scientific progress possible. It’s what allows companies to be legitimate partners in advancing medicine.

For everyone else in healthcare: trust isn’t a soft skill or nice-to-have. It’s the infrastructure on which everything else is built.

Practical 5 Steps

A practical 5-step guide for Medical Affairs teams

1. Define the patient-centered aim of each activity (exchange, education, or datageneration). Document how it advances science and patient care, not product promotion.
2. Involve independent scientific leaders early. Co-create topics, protocols, and educational content with a diverse group of experts.
3. Build neutral, high-quality content. Prioritize methodological rigor, balanced discussion, and real-world relevance. Use Briefio to maintain accuracy and accessibility of complex material.
4. Implement transparent governance. Separate funding decisions from scientific execution; publish authorship plans and trial or study results clearly; communicate any conflicts of interest.
5. Measure trust-building outcomes. Track attendee satisfaction, knowledge uptake, quality of discourse, and downstream scholarly activity. Use insights to refine future programs.

Briefio helps scientists, physicians, and lifelong learners stay current with scientific literature by converting dense papers into easy-to-digest audio summaries. Available now in the App Store. Learn more at briefio.app